Pfizer raises 2021 sales forecast for Covid vaccines to $26 billion
The company is ramping up capacity for the shots, which were developed with German company BioNTech Pfizer sharply increased its projections for 2021 revenues and profits on Tuesday, citing much higher COVID-19 vaccine sales as it targets the inoculations as a "durable" revenue stream. The drugmaker, which has a number of projects to expand vaccinations to additional populations and to provide booster doses, now estimates 2021 revenues of $26 billion from the vaccine, up from $15 billion previously. Watch | Pfizer now sees profits of between $3.55 and $3.65 a share for the year, an increase...
Source: wionews.com